Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

Takeda can't sway NICE on oral myeloma therapy Ninlaro

Takeda can't sway NICE on oral myeloma therapy Ninlaro It is indicated for use alongside Celgene's blockbuster immunomodulatory drug Revlimid (lenalidomide) and dexamethasone.

Celgene joins PD-1 race via partnership with BeiGene

Celgene joins PD-1 race via partnership with BeiGene BeiGene is also acquiring Celgene's commercial operations in Asia with the right to sell blood cancer therapies Revlimid (lenalidomide) and Vidaza (azacitidine) and Abraxane (albumin-bound paclitaxel) for pancreatic cancer -

FDA halts third Merck myeloma trial after patient deaths

FDA halts third Merck myeloma trial after patient deaths More patients taking Merck's drug died than those getting other treatment in the three trials, which all involved combinations of Keytruda with Celgene's Pomalyst (pomalidomide) and Revlimid (lenalidomide), two ... carfilzomib) - in heavily pre-treated

Merck suspends two Keytruda trials after patient deaths

Merck suspends two Keytruda trials after patient deaths Investigators to look at Keytruda with Pomalyst and Revlimid. Merck &Co has paused patient enrolment in two trials of Keytruda to allow investigators to explore reports of deaths among patients taking ... The two trials - KEYNOTE-183 and KEYNOTE-185 -

J&J gets CHMP backing for broader Darzalex use

J&J gets CHMP backing for broader Darzalex use Celgene's Revlimid (lenalidomide) plus dexamethasone and Takeda's Velcade (bortezomib) plus dexamethasone - have already been tried.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...
2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....

Infographics